We are live on ! Find out more
CG

Cynosure Group Portfolio holdings

AUM $800M
1-Year Est. Return 16.39%
This Fund
S&P 500
This Quarter Est. Return
-0.17%
1 Year Est. Return
+16.39%
3 Year Est. Return
+48.93%
5 Year Est. Return
+61.83%
10 Year Est. Return
AUM
$983M
AUM Growth
+$62.4M
Cap. Flow
+$1.21B
Cap. Flow %
123.15%
Top 10 Hldgs %
53.1%
Holding
539
New
168
Increased
108
Reduced
93
Closed
140

Sector Composition

Rank Sector Weight
1 Financials 7.56%
2 Industrials 7.53%
3 Healthcare 6.75%
4 Technology 6.66%
5 Consumer Discretionary 2.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MA icon
101
Mastercard
MA
$498B
$658K 0.07%
1,153
+255
+28% +$143K
SHOP icon
102
Shopify
SHOP
$168B
$644K 0.07%
4,000
AXSM icon
103
Axsome Therapeutics
AXSM
$11.7B
$635K 0.06%
3,475
-4,369
-56% -$610K
IAU icon
104
iShares Gold Trust
IAU
$62.8B
$634K 0.06%
7,814
-58
-0.7% -$4.54K
MGK icon
105
Vanguard Mega Cap Growth ETF
MGK
$31.3B
$625K 0.06%
7,565
ENVA icon
106
Enova International
ENVA
$6.09B
$621K 0.06%
3,949
-4,490
-53% -$584K
NDSN icon
107
Nordson
NDSN
$16.4B
$616K 0.06%
2,562
TJX icon
108
TJX Companies
TJX
$179B
$613K 0.06%
3,991
+348
+10% +$51.5K
BIZD icon
109
VanEck BDC Income ETF
BIZD
$1.6B
$605K 0.06%
42,692
-130,467
-75% -$1.87M
IEMG icon
110
iShares Core MSCI Emerging Markets ETF
IEMG
$144B
$600K 0.06%
8,927
-380
-4% -$25.5K
LLY icon
111
Eli Lilly
LLY
$1.08T
$599K 0.06%
557
-804
-59% -$769K
MRK icon
112
Merck
MRK
$322B
$598K 0.06%
5,683
-76
-1% -$7.13K
MDGL icon
113
Madrigal Pharmaceuticals
MDGL
$12.6B
$597K 0.06%
+1,025
New +$524K
KRYS icon
114
Krystal Biotech
KRYS
$10.7B
$593K 0.06%
2,406
-3,512
-59% -$739K
ACWX icon
115
iShares MSCI ACWI ex US ETF
ACWX
$11.2B
$590K 0.06%
8,794
EXPE icon
116
Expedia Group
EXPE
$36.5B
$579K 0.06%
+2,044
New +$505K
CMI icon
117
Cummins
CMI
$83.6B
$575K 0.06%
+1,127
New +$527K
ENTG icon
118
Entegris
ENTG
$16.3B
$573K 0.06%
+6,804
New +$591K
IWR icon
119
iShares Russell Mid-Cap ETF
IWR
$55.9B
$573K 0.06%
5,968
-1,193
-17% -$115K
RSG icon
120
Republic Services
RSG
$67.4B
$570K 0.06%
2,689
+836
+45% +$180K
TMO icon
121
Thermo Fisher Scientific
TMO
$214B
$567K 0.06%
979
-1,362
-58% -$770K
BMY icon
122
Bristol-Myers Squibb
BMY
$129B
$565K 0.06%
+10,475
New +$504K
ABNB icon
123
Airbnb
ABNB
$90.8B
$565K 0.06%
4,161
MOH icon
124
Molina Healthcare
MOH
$10.4B
$557K 0.06%
3,211
+2,099
+189% +$345K
ACGL icon
125
Arch Capital
ACGL
$36.5B
$551K 0.06%
5,749
+2,039
+55% +$187K

Similar funds

Cynosure Group's Q4 2025 Portfolio in Review

As of Q4 2025, Cynosure Group held 539 positions worth $983M, up 6.8% from $921M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Cynosure Group deployed $1.21B of net new capital in Q4 2025, opening 168 new positions and adding to 108 existing holdings. Its largest new stake was Circle Internet Group: 343,129 shares worth $27.2M.

By sector, the portfolio is most concentrated in Financials at 7.6% of assets, up from 5% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard Russell 1000 Growth ETF, an estimated $30.7M trimmed.

  • Cynosure Group's largest Q4 2025 buy was Circle Internet Group: 343,129 shares worth $27.2M.
  • Cynosure Group added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $586M increase.
  • Cynosure Group's biggest Q4 2025 reduction was Vanguard Russell 1000 Growth ETF, cutting an estimated $30.7M.
  • Cynosure Group fully exited Black Rock Coffee Bar Inc in Q4 2025, selling an estimated $7.54M.
  • Cynosure Group's ten largest holdings make up 53% of its $983M portfolio in Q4 2025.
  • Cynosure Group opened 168 new positions and closed 140 in Q4 2025.
  • Cynosure Group's portfolio value rose 6.8% quarter-over-quarter to $983M.

Based on Cynosure Group's 13F filing for Q4 2025, filed 17 Feb 2026.